JPH0351062A - Iontophoresis device - Google Patents
Iontophoresis deviceInfo
- Publication number
- JPH0351062A JPH0351062A JP19001289A JP19001289A JPH0351062A JP H0351062 A JPH0351062 A JP H0351062A JP 19001289 A JP19001289 A JP 19001289A JP 19001289 A JP19001289 A JP 19001289A JP H0351062 A JPH0351062 A JP H0351062A
- Authority
- JP
- Japan
- Prior art keywords
- electrode
- contact
- chemical
- kept
- generation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Electrotherapy Devices (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、直流電流によるイオンの流動を利用して、薬
物を皮膚又は粘膜に注入するイオントフォレーシス装置
に関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to an iontophoresis device that injects a drug into the skin or mucous membrane using ion flow caused by direct current.
従来技術とその問題点
内服薬は、患部に供給される必要量の100倍以上を服
用する必要があるが、イオントフォレーVy−によれば
、局部に注入できるので1/100の量でよい。又、貼
り薬が提案されているが、これは吸収が遅い。イオント
フオレ++Pスによれば、数十倍から数百倍の早さで吸
収される。Conventional technology and its problems Oral medicine requires taking 100 times or more of the required amount to be supplied to the affected area, but with iontophoresis Vy-, the amount can be 1/100 because it can be injected locally. In addition, topical patches have been proposed, but these are slow to be absorbed. According to iontophores++Ps, it is absorbed several tens to hundreds of times faster.
さらに、注射の場合のように、注射針による痛みや、感
染の危険を伴わずに薬の投与ができる。Furthermore, medicines can be administered without the pain of needles and the risk of infection, as is the case with injections.
イオントフォレーVスは、上述のようにメリットがある
が、消費電力の大部分が水の電解に消費されてしまう点
に問題があった。Although iontophores have advantages as mentioned above, there is a problem in that most of the power consumption is consumed for water electrolysis.
発明の目的
本発明は、上記の欠点を除くもので、水電解による消費
エネルギーな最小にし、電気エネルギーの大部分な薬注
エネルギーに利用するイオントフォレーシス装置を提供
することを目的とする。OBJECTS OF THE INVENTION The present invention eliminates the above-mentioned drawbacks, and aims to provide an iontophoresis device that minimizes the energy consumption due to water electrolysis and utilizes most of the electrical energy for chemical injection energy.
発明の構成
本発明は上記目的を達成するべく、
皮膚又は粘膜に電圧を印加し、電気的に薬剤な泳動せし
めて、人体に注入するイオントフォレーシス装置におい
て、薬剤溶液と接触する染除電極の表面に、水電解によ
るガス発生を低下せしめる物質を配置せしめることを特
徴とするイオントフォレーシス装置である。又、電極表
面に重金属を配置せしめた前記イオントフォレーシス装
置である。Structure of the Invention In order to achieve the above-mentioned object, the present invention provides a decontamination electrode that comes into contact with a drug solution in an iontophoresis device that applies a voltage to the skin or mucous membrane, electrophoresizes the drug, and injects it into the human body. This is an iontophoresis device characterized in that a substance that reduces gas generation due to water electrolysis is placed on the surface of the iontophoresis device. Further, the present invention is the above-mentioned iontophoresis device in which heavy metals are arranged on the electrode surface.
作用
皮膚又は粘りに電圧を印加し、薬剤な経皮注入する装置
において、電極表面の金属を陽極は酸素発生の少ない物
質、陰極は水素発生の少ない物質な゛配し、電極表面か
らの水電解によるガス発生を抑制した。In a device that applies a voltage to the skin or the skin and injects drugs transdermally, the metal on the electrode surface is arranged such that the anode is a material that generates little oxygen and the cathode is a material that generates little hydrogen. suppressed gas generation caused by
実施例
以下1本発明の詳細について一実施例により説明する・
第1図は、本発明の一実施例によるイオントフォレーV
ス装置の模式図であり、第1図において、1は直流電圧
を印加するための薄型電池、2は陽極で表面が金の電極
、3の生理食塩水に薬剤を溶解させた電解液が接してい
る。4は陰極で表面が亜鉛の電極で、5のガーゼに含ま
せた生理食塩水と接している。EXAMPLE Below 1 Details of the present invention will be explained by way of an example. Figure 1 shows an iontophoret V according to an example of the present invention.
In Fig. 1, 1 is a thin battery for applying a DC voltage, 2 is an anode with a gold surface, and 3 is an electrolytic solution in which a drug is dissolved in physiological saline. ing. 4 is a cathode, which is an electrode with a zinc surface, and is in contact with the physiological saline soaked in gauze 5.
第2図は、電極の相違による効果を確認するための、試
験装置の模式図であり、6の印加電圧を可変できる直流
電源の他は、上記の実施例と同一の構成である。7は皮
膚である。FIG. 2 is a schematic diagram of a test apparatus for confirming the effects of different electrodes, and the test apparatus has the same configuration as the above embodiment except for the DC power supply 6 which can vary the applied voltage. 7 is the skin.
本発明の実施例において、陽極に金、陰極に亜鉛を用い
たイオントフォレーVス装置な!とし、従来の、陽極、
陰極ともに、白金を用いたイオントフォレーVス装置な
菖として、電極面積が1d1通電時間5分で、同一量の
薬剤を注入するのに必要な印加電圧を第2図の試験装置
陽極の電極材料としては、金のほかに、白金、イリジウ
ム〜ロジクム、ニッケμがガスの発生を抑える効果があ
り、陰極のwL電極材料しては、亜鉛のほか、鉛、銅、
銀が有効であった。In an embodiment of the present invention, an iontophoresis device using gold as an anode and zinc as a cathode is used! and conventional anode,
Both the cathode and the cathode are iontophoresis device using platinum.The electrode area is 1d1 and the current application time is 5 minutes. In addition to gold, platinum, iridium to rhodicum, and nickel μ have the effect of suppressing gas generation.As for the cathode wL electrode materials, in addition to zinc, lead, copper,
Silver was effective.
以上のように本発明によれば、電・極からのガスの発生
が抑えられるので、薬剤の注入が効率よく行なえること
から、電池の電圧を低く設定でき安全性が向上する効果
が得られる。As described above, according to the present invention, the generation of gas from the electrodes is suppressed, so that the drug can be injected efficiently, and the battery voltage can be set low, resulting in the effect of improving safety. .
発明の効果
上述した如く、本発明は水電解による消費エネルギーを
最小にし、電気エネルギーの大部分を薬注エネルギーに
利用するイオンドアオレーV7装置を提供することが出
来るので、その工業的価値は極めて大である。Effects of the Invention As mentioned above, the present invention can provide an ion door array V7 device that minimizes the energy consumed by water electrolysis and uses most of the electrical energy for chemical injection energy, so its industrial value is extremely high. It's large.
第1図は本発明の一実施例によるイオントフォレーVス
装置の模式図であり、第2図は、試験装置の模式図であ
る。
1・・・電池 2・・・陽極3・・・
薬剤含有生理食塩水 4・・・陰極5・・・生理食塩
水 6・・・直流電源7・・・皮膚FIG. 1 is a schematic diagram of an iontophoresis device according to an embodiment of the present invention, and FIG. 2 is a schematic diagram of a test device. 1...Battery 2...Anode 3...
Drug-containing physiological saline 4...Cathode 5...Physiological saline 6...DC power supply 7...Skin
Claims (2)
て、人体に注入するイオントフォレーシス装置において
、薬剤溶液と接触する陽陰電極の表面に、水電解による
ガス発生を低下せしめる物質を配置せしめたことを特徴
とするイオントフォレーシス装置。(1) In iontophoresis devices that apply voltage to the skin, electrophores the drug, and inject it into the human body, reduce gas generation due to water electrolysis on the surfaces of the positive and negative electrodes that come into contact with the drug solution. An iontophoresis device characterized by having a substance arranged therein.
イオントフォレーシス装置。(2) The iontophoresis device according to claim 1, wherein a heavy metal is arranged on the surface of the electrode.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19001289A JP2793638B2 (en) | 1989-07-20 | 1989-07-20 | Iontophoresis device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19001289A JP2793638B2 (en) | 1989-07-20 | 1989-07-20 | Iontophoresis device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0351062A true JPH0351062A (en) | 1991-03-05 |
| JP2793638B2 JP2793638B2 (en) | 1998-09-03 |
Family
ID=16250906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19001289A Expired - Fee Related JP2793638B2 (en) | 1989-07-20 | 1989-07-20 | Iontophoresis device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2793638B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034657A1 (en) | 1996-03-17 | 1997-09-25 | Hisamitsu Pharmaceutical Co., Inc. | Electrode device for iontophoresis |
-
1989
- 1989-07-20 JP JP19001289A patent/JP2793638B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034657A1 (en) | 1996-03-17 | 1997-09-25 | Hisamitsu Pharmaceutical Co., Inc. | Electrode device for iontophoresis |
| US6330471B1 (en) | 1996-03-17 | 2001-12-11 | Hisamitsu Pharmaceutical Co., Ltd. | Iontophoresis electrode device |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2793638B2 (en) | 1998-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chien et al. | Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices | |
| EP0258392B1 (en) | Apparatus for iontophoretic drug-delivery | |
| Brummer et al. | Electrical stimulation of the nervous system: the principle of safe charge injection with noble metal electrodes | |
| JP4180244B2 (en) | Electrical transfer system with internal sensor | |
| Banga et al. | Iontophoresis and electroporation: comparisons and contrasts | |
| Bommannan et al. | Effect of electroporation on transdermal lontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro | |
| Tyle | Lontophoretic devices for drug delivery | |
| CN1607970B (en) | Skin patch | |
| JPS63102768A (en) | Novel plaster structure for iontophoresis | |
| US20010044592A1 (en) | Methods for delivering agents using alternating current | |
| EP0400118A1 (en) | Electrode for IONTOPHORESIS. | |
| CN1606461A (en) | Device and method for controlled delivery of active substance into the skin | |
| US6355025B1 (en) | Adjustable electrotransport drug delivery using a fixed output controller | |
| JPH06506616A (en) | Device for reducing stimulation during iontophoresis drug administration | |
| KR880701573A (en) | Ionization Devices and Methods and Unit Capacity | |
| EP1633431A1 (en) | Kit, device and method for controlled delivery of oxidizing agent into the skin | |
| US5766144A (en) | High efficiency electrode system for iontophoresis | |
| US20070016277A1 (en) | Lip augmentation device | |
| US6375990B1 (en) | Method and devices for transdermal delivery of lithium | |
| JPH04224770A (en) | Apparatus for iontophoresis | |
| US5983132A (en) | Ionophoretic device for transdermal administration of medicaments, and disposable assembly forming part of such device | |
| Haga et al. | Transdermal iontophoretic delivery of insulin using a photoetched microdevice | |
| Banga et al. | Clinical applications of lontophoretic devices in rehabilitation medicine | |
| Banga et al. | A review of patent literature for iontophoretic delivery and devices | |
| JPH0351062A (en) | Iontophoresis device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |